◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › DVA

DaVita HealthCare Partners Inc (DVA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Services · DATA UPDATED 2026-07-19

DaVita HealthCare Partners Inc (DVA) operates in the Health Care Services industry and is headquartered in Denver, United States with about 78,000 employees. Its market capitalization is roughly $15 billion. In the fiscal year ended 2025-12-31, DVA reported $13.6B in revenue and $747M in net income.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

Interactive charts & full statements → Open the DVA valuation workbench →

DVA Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$13.8B	$13.6B	$12.8B	$12.1B	$11.6B	$11.6B	$11.6B	$11.4B	$11.4B	$10.9B	$14.7B	$13.8B	$12.8B	$11.8B	$8.2B	$6.8B	$6.4B	$6.1B	$5.7B	$5.3B	$4.9B
Gross Profit	$4.3B	$3.7B	$4.2B	$3.8B	$3.4B	$3.6B	$3.6B	$3.5B	$3.2B	$3.2B	$3.3B	$3.1B	$3.7B	$3.6B	$2.6B	$2.1B	$1.8B	$1.9B	$1.7B	$1.7B	$1.5B
Gross Margin %	31.1%	27.0%	32.9%	31.5%	29.3%	31.4%	30.8%	30.5%	28.1%	29.8%	22.2%	22.7%	28.7%	30.3%	31.8%	30.9%	27.8%	30.4%	30.7%	31.8%	30.5%
Operating Income (EBIT)	$2.1B	$2.0B	$2.1B	$1.6B	$1.3B	$1.8B	$1.7B	$1.6B	$1.5B	$1.8B	$2.0B	$1.1B	$1.8B	$1.6B	$1.3B	$1.2B	$994M	$940M	$869M	$862M	$739M
Operating Margin %	15.0%	14.7%	16.3%	13.2%	11.5%	15.5%	14.7%	14.4%	13.4%	16.7%	13.8%	8.2%	14.2%	13.2%	15.8%	17.0%	15.4%	15.4%	15.3%	16.4%	15.2%
Net Income	$781M	$747M	$936M	$692M	$560M	$978M	$774M	$811M	$159M	$664M	$880M	$270M	$723M	$633M	$536M	$478M	$406M	$423M	$374M	$382M	$290M
Net Margin %	5.7%	5.5%	7.3%	5.7%	4.8%	8.4%	6.7%	7.1%	1.4%	6.1%	6.0%	2.0%	5.7%	5.4%	6.6%	7.0%	6.3%	6.9%	6.6%	7.2%	5.9%
EBITDA	$2.7B	$2.6B	$2.7B	$2.3B	$2.1B	$2.5B	$2.3B	$2.3B	$2.1B	$2.6B	$2.8B	$1.7B	$2.3B	$2.1B	$1.6B	$1.4B	$1.2B	$1.2B	$1.1B	$1.1B	$913M
Earnings Per Share (EPS)	$10.14	$8.48	$10.73	$7.42	$5.85	$8.90	$6.31	$5.27	$0.92	$3.47	$4.29	$1.25	$3.33	$2.95	$2.74	$2.48	$1.97	$2.03	$1.77	$1.78	$1.37
Shares Outstanding (M)	69M	88M	87M	93M	96M	110M	123M	154M	172M	191M	205M	216M	217M	215M	196M	193M	206M	208M	212M	215M	212M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DVA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$3.4B	$3.6B	$3.4B	$3.4B	$3.2B	$3.3B	$3.3B	$3.2B
Gross Profit	$1.1B	$1.0B	$1.1B	$1.1B	$984M	$1.1B	$1.1B	$1.0B
Gross Margin %	31.4%	28.3%	31.8%	33.1%	30.5%	32.5%	34.1%	32.8%
Operating Income (EBIT)	$482M	$551M	$506M	$538M	$439M	$565M	$535M	$506M
Operating Margin %	14.1%	15.2%	14.8%	15.9%	13.6%	17.2%	16.4%	15.9%
Net Income	$198M	$234M	$150M	$199M	$163M	$259M	$215M	$223M
Net Margin %	5.8%	6.5%	4.4%	5.9%	5.1%	7.9%	6.6%	7.0%
EBITDA	$655M	$718M	$637M	$690M	$598M	$727M	$695M	$645M
Earnings Per Share (EPS)	$2.87	$2.66	$2.04	$2.58	$2.00	$3.02	$2.50	$2.50
Shares Outstanding (M)	69M	88M	74M	77M	81M	86M	86M	89M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DVA Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$2.0B	$1.9B	$2.0B	$2.1B	$1.6B	$1.9B	$2.0B	$2.1B	$1.8B	$1.9B	$2.0B	$1.6B	$1.5B	$1.8B	$1.1B	$1.2B	$840M	$667M	$556M	$533M	$520M
Capital Expenditures (CapEx)	$535M	$576M	$555M	$568M	$603M	$641M	$675M	$767M	$987M	$905M	$829M	$708M	$642M	$621M	$550M	$400M	$274M	$275M	$318M	$275M	$268M
Free Cash Flow (FCF)	$1.5B	$1.3B	$1.5B	$1.5B	$961M	$1.3B	$1.3B	$1.3B	$785M	$1.0B	$1.1B	$849M	$817M	$1.2B	$551M	$780M	$566M	$392M	$238M	$259M	$251M
FCF Margin %	10.8%	9.6%	11.4%	12.3%	8.3%	11.1%	11.3%	11.5%	6.9%	9.2%	7.7%	6.2%	6.4%	9.8%	6.7%	11.5%	8.8%	6.4%	4.2%	4.9%	5.1%
Dividends Paid	—	—	—	—	$268M	$244M	$253M	$11M	$196M	$211M	$192M	$175M	$149M	$139M	$140M	$114M	$84M	$68M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DVA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$321M	$541M	$841M	$324M	$180M	$548M	$810M	$799M
Capital Expenditures (CapEx)	$102M	$145M	$166M	$121M	$143M	$171M	$139M	$125M
Free Cash Flow (FCF)	$219M	$395M	$675M	$203M	$37M	$377M	$671M	$674M
FCF Margin %	6.4%	10.9%	19.7%	6.0%	1.1%	11.4%	20.6%	21.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DVA Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$17.5B	$17.5B	$17.3B	$16.9B	$16.9B	$17.1B	$17.0B	$17.3B	$19.1B	$18.9B	$18.7B	$18.5B	$17.9B	$17.1B	$16.0B	$8.9B	$8.1B	$7.6B	$7.3B	$6.9B	$6.5B
Cash & Cash Equivalents	$726M	$758M	$795M	$380M	$244M	$462M	$325M	$1.1B	$323M	$508M	$913M	$1.5B	$965M	$946M	$534M	$394M	$860M	$539M	$411M	$447M	$310M
Total Liabilities	$16.5B	$16.3B	$15.2B	$14.2B	$14.7B	$14.8B	$14.1B	$13.8B	$14.1B	$13.1B	$12.9B	$12.5B	$11.8B	$11.8B	$11.5B	$6.6B	$6.1B	$5.4B	$5.2B	$5.1B	$5.1B
Total Debt (Short + Long-Term)	$11.1B	$10.7B	$9.9B	$8.8B	$9.3B	$9.3B	$8.5B	$8.5B	$10.1B	$9.3B	$9.1B	$9.1B	$8.5B	$8.4B	$8.6B	$4.5B	$4.3B	$3.6B	$3.7B	$3.7B	$3.8B
Total Shareholders' Equity	($755M)	$1.2B	$2.1B	$2.7B	$2.2B	$2.4B	$2.9B	$3.5B	$5.0B	$5.9B	$5.8B	$5.9B	$6.2B	$5.3B	$4.5B	$2.3B	$2.0B	$2.2B	$2.1B	$1.9B	$1.4B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DVA viewer.

Other Companies in Health Care Services

CVS · CVS Health — $137 billion
CI · Cigna — $77 billion
DGX · Quest Diagnostics — $25 billion
LH · Labcorp — $24 billion

← DV All stocks DVLT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.